Aurobindo Pharma gets USFDA approval for Cefadroxil oral suspension

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cefadroxil for Oral Suspension USP 250mg/5mL and 500mg/5mL (ANDA 065349).

April 26, 2013 / 14:50 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated April 26, 2013 titled "Aurobindo Pharma receives USFDA Approval for Cefadroxil Oral Suspension".

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cefadroxil for Oral Suspension USP 250mg/5mL and 500mg/5mL (ANDA 065349).Source : BSE

Read all announcements in Aurobindo Pharm

first published: Apr 26, 2013 02:50 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347